| Literature DB >> 28526080 |
Mohamed Rhouma1, John Morris Fairbrother2, Francis Beaudry3, Ann Letellier2.
Abstract
Post-weaning diarrhea (PWD) is one of the most serious threats for the swine industry worldwide. It is commonly associated with the proliferation of enterotoxigenic Escherichia coli in the pig intestine. Colistin, a cationic antibiotic, is widely used in swine for the oral treatment of intestinal infections caused by E. coli, and particularly of PWD. However, despite the effectiveness of this antibiotic in the treatment of PWD, several studies have reported high rates of colistin resistant E. coli in swine. Furthermore, this antibiotic is considered of very high importance in humans, being used for the treatment of infections due to multidrug-resistant (MDR) Gram-negative bacteria (GNB). Moreover, the recent discovery of the mcr-1 gene encoding for colistin resistance in Enterobacteriaceae on a conjugative stable plasmid has raised great concern about the possible loss of colistin effectiveness for the treatment of MDR-GNB in humans. Consequently, it has been proposed that the use of colistin in animal production should be considered as a last resort treatment only. Thus, to overcome the economic losses, which would result from the restriction of use of colistin, especially for prophylactic purposes in PWD control, we believe that an understanding of the factors contributing to the development of this disease and the putting in place of practical alternative strategies for the control of PWD in swine is crucial. Such alternatives should improve animal gut health and reduce economic losses in pigs without promoting bacterial resistance. The present review begins with an overview of risk factors of PWD and an update of colistin use in PWD control worldwide in terms of quantities and microbiological outcomes. Subsequently, alternative strategies to the use of colistin for the control of this disease are described and discussed. Finally, a practical approach for the control of PWD in its various phases is proposed.Entities:
Keywords: Alternatives; Colistin; E. coli; Pigs; Post-weaning diarrhea; Resistance
Mesh:
Substances:
Year: 2017 PMID: 28526080 PMCID: PMC5437690 DOI: 10.1186/s13028-017-0299-7
Source DB: PubMed Journal: Acta Vet Scand ISSN: 0044-605X Impact factor: 1.695
Fig. 1The multifactorial genesis of post weaning diarrhea (PWD) in pigs involves interaction between predisposing, contributing and determining factors. PW Post weaning, ETEC enterotoxigenic Escherichia coli, EPEC enteropathogenic Escherichia coli
Fig. 2Schematic representation of the steps involved in the pathogenesis of post weaning diarrhea in pigs
Microbiological and clinical outcomes of monotherapy with colistin in pigs
| Bacterial agents/condition | Dose per day | Duration (days) | Sample type | Reduction | Performance (ADG, g/day) | References |
|---|---|---|---|---|---|---|
|
| 300 mg/kg of diet | 7 | Ileum | 6.55 | 122b | [ |
| Cecum | 6.63 | |||||
|
| 300 mg/kg of diet | 10 | Ileum | 2.3 | 128a | [ |
| Cecum | 3.2 | |||||
| Weaned pigs (clinically healthy) | 200 mg/kg of diet | 7 | N/A | N/A | 229a | [ |
| ETEC mixture/experimental PWD | 200 mg/kg of diet | 21 | Ileum | 1.54 | 292b | [ |
| Cecum | 1.65 | |||||
| Colon | 0.65 | |||||
| ETEC mixture/experimental PWD | 2.5 mg/animal (Oral-Water) | 21 | Fecal samples | 3 | 283b | [ |
| Weaned pigs (clinically healthy) | 40 mg/kg of diet | 14 | Ileum | N/A | 142.2a | [ |
| Cecum | ||||||
| Colon | ||||||
|
| 4.8 mg/kg (Oral-Water) | 5 | Fecal samples | 4 | 214a | [ |
|
| 9.6 mg/Kg (Oral-Water) | 5 | Fecal samples | 4 | N/A | [ |
| Weaned pigs (clinically healthy) | 172.8 mg/kg of diet | 14 | Fecal samples | 4.5d | N/A | [ |
PWD post-weaning diarrhea, ADG average daily weight gain, N/A not available, ETEC enterotoxigenic Escherichia coli
aNot statistically significant compared to the control group
bStatistically significant compared to the control group
cReduction compared to the control group
dlog cfu of Enterobacteriaceae/g
Preventive strategies to reduce the use of antimicrobials during the post-weaning period
| Strategies | Benefits | Limitations | References |
|---|---|---|---|
| Control of housing environment and improved biosecurity | Very effective approach | Significant cost | [ |
| Significantly reduces PWD occurrence | Extreme weather conditions in some countries | ||
| Reduces the use of antimicrobials in farm | Acceptability of farmers to change some management techniques | ||
| Sustainable approach | Financial support is required | ||
| Diet management (reducing the amount of soybean) | Reduces the severity and frequency of PWD and oedema disease | Growth retardation | [ |
| Increase production | |||
| Reduction of histological changes in intestinal crypt and villi | Considerable controversy between studies | ||
| Communicative advisory tools for pig farmers | Improving breeding management | Requires a lot of field work | [ |
| Farmers feel concerned by the problem of antibiotic resistance | Farmers worried mostly about infectious diseases and financial issues | ||
| Raised awareness and responsibility | Financial bonus is required | ||
| Laboratory diagnosis to confirm etiology of PWD | Avoid the use of antimicrobials to treat viral diarrhea | Significant cost | [ |
| Allows an appropriate choice for antibiotics | Lack of rapid diagnostic techniques | ||
| Policy measures | Reduce the sale and the use of antimicrobials on farm | Requires penalties | [ |
| Reduce self-medication | Financial bonus is required | ||
| Immunoprophylaxis: Live attenuated and live wild type avirulent | Specific protection against ETEC: F4 or F18 | Interference with the lactogenic immunity of piglets | [ |
| Easy to administer on farms (drinking water) | Absence of cross-protection between F18ab strains | ||
| Reduces antimicrobial use in the PW period | Limited availability in some countries | ||
| Marketed in swine | |||
| Immunoprophylaxis: Subunit vaccines (purified F4 fimbriae) | A powerful oral immunogen | The proposed immunization procedure required large quantities of F4 | [ |
| Leads to a specific mucosal immune response | Antigen degraded by the pH of the stomach and by digestive enzymes | ||
| Leads to a significant reduction in fecal excretion of ETEC: F4 | Usually required mucosal adjuvant such as Cholera toxin | ||
| Breeding of resistant pigs | Very effective approach | Expensive process | [ |
| Greatly reduces the total amount of antimicrobials used on farms | Lack of techniques for a large-scale selection | ||
| Reduces the selection pressure | Development of other adherence mechanisms |
PWD post weaning diarrhea
Benefits and limitations of the major alternative feed strategies for the control of post weaning diarrhea (PWD) in pigs
| Strategies | Benefits | Limitations | References |
|---|---|---|---|
| Zinc oxide | Inhibition of bacterial adhesion to the intestinal mucosa | High levels increased PWD | [ |
| Stimulated growth rate | Soil heavy metal contamination | ||
| Maintained intestinal mucosal integrity | Bacterial resistance | ||
| Modulated immune functions | Co-resistance | ||
| Organic acids | Decreased pH in the stomach | Exact modes of action still unknown | [ |
| Improved growth performance | Anti microbial activities is different between acids | ||
| Reduced PWD | |||
| Prebiotics, probiotics and synbiotics | Improved intestinal health | Sometimes contradictory studies on their effectiveness | [ |
| Improved growth performance | Lack of information on the potential synergism between pre- and probiotics | ||
| Reduced ETEC: F4 attachment to the ileal mucosa | |||
| Reduced diarrhea | |||
| Spray dried plasma (SDP) | Improved growth performance | High cost | [ |
| Reduced incidence and severity of diarrhea | Required rigorous control during the preparation process | ||
| Reduced the markers of intestinal inflammation | Potential source of pathogens? | ||
| Maintained mucosal integrity | |||
| Antimicrobial peptides (AMPs) | Improved growth performance | The pharmacokinetics in vivo is unknown | [ |
| Decreased diarrhea | Bacterial resistance | ||
| Reduced the markers of intestinal inflammation | |||
| Enhance immune function | |||
| Cocktails of AMPs might be used to mitigate selection for resistance | |||
| Specific egg yolk antibodies | Improved growth performance | High cost | [ |
| Decreased diarrhea | Antibodies are sometime not specific against the infecting ETEC strains on farms | ||
| Maintained intestinal mucosal integrity | |||
| Bacteriophages | Reduced | Narrow spectrum of activity | [ |
| Maintained intestinal mucosal integrity | Development of bacterial resistance | ||
| Decreased diarrhea | A combination of phages is needed |
Effects of colistin compared to alternative measures for control of post weaning diarrhoea (PWD) in pigs
| Trials | ADG (g/day) | Ileum villus height (μm) | Ileum crypt depth (μm) |
| Diarrhea | References |
|---|---|---|---|---|---|---|
| Study 1: HP | d0–35 | d35 | d35 | d0–21c | [ | |
| Hop β-acidse (360 mg/kg) | 441a | 337 | 214 | NA | 1.51 | |
| Colistin sulfate (40 mg/kg) | 425a | 366 | 230 | NA | 1.51 | |
| Control | 387b | 349 | 219 | NA | 1.72 | |
| Study 2: HP | d21 | d21 | d21 | d21 | [ | |
| Two | NA | 121 | 66.30 | 7.93a | NA | |
| Colistin sulfate (300 mg/kg) | NA | 107 | 57.63 | 6.48a | NA | |
| Control | NA | 120.49 | 64.75 | 6.63 | NA | |
| Study 3: HP | d1–21 | d21 | d21 | Ileum d21f | d1–7c | [ |
| Recombinant plectasin (Ple) (60 mg/kg) | 311.43a | 227.69 | 95.53 | 6.61 | 10.48 | |
| Colistin sulfate (60 mg/kg) | 333.57a | 195.57 | 88.48 | 5.86 | 8.57 | |
| Control | 193.10b | 160.45 | 105.82 | 6.29 | 36.19 | |
| Study 4: HP | d0–14 | d0–14 | [ | |||
| Medium-chain triglyceride (MCT) (3000 mg/kg) | 141.2 | NA | NA | NA | 0.91 | |
| Colistin sulfate (40 mg/kg | 142.2 | NA | NA | NA | 0.91 | |
| Control | 130.7 | NA | NA | NA | 1.01 | |
| Study 5: HP | d28–56 | d42 | d42 | d28–56d | [ | |
| Freshwater microalgae | 395 | 435 | 278 | NA | 24b | |
| Colistin sulfate (20 mg/kg) | 400 | 440 | 283 | NA | 34a | |
| Control | 393 | 415 | 299 | NA | 36a | |
| Study 6: CP | d1 post challengee | d1 post challengee | [ | |||
| Live yeast (5 × 1010 CFU/kg) | NA | 322 | 246 | NA | NA | |
| Colistin sulfate (1000 mg/kg) | NA | 334 | 236 | NA | NA | |
| Control | NA | 294 | 199 | NA | NA |
Live yeast: Saccharomyces cerevisiae
HP healthy pigs, CP challenged pigs, NA not available
a,bValues within a row with different superscripts differ significantly at P < 0.05
cDiarrhea occurrence was calculated as the proportion of days in which pigs showed clinical signs of diarrhea
dNumber of pig days with diarrhoea score ≥2
eJejunum
flog (copies/g)
Fig. 3Illustrative interventions for the management of post-weaning diarrhea in pig farms. Asterisk Vaccination just prior to or at weaning
(Inspired from [159])